Optibiotix Health Share Discussion Threads

[bobdown2] 18/1/2017 09:00

Today it looks like we have another confirmation that it is not just go figure ready for the market. We now have two big sales people joined. Also the seller may have stopped and we are awaiting news from the Asian company. I topped up first thing..

[scotty1] 18/1/2017 09:00

Owenmo why do you " find it more than a little disconcerting" people buy people sell what do you want em to do hold em all until they kick the bucket.

[someuwin] 18/1/2017 08:58

"...One company which has been exploring the link between gut bacteria and weight loss for a while now is OptiBiotix Health plc (LON:OPTI).

Its Slimbiome ingredients – which are used in the GoFigure range of products – increase the microbial diversity and numbers of healthy bacteria in your gut.

“The greater the microbial diversify the more likely you are to be able to diet more easily and sustain that weight loss,” says OptiBiotix’s chief executive Stephen OHara.

“[Using our products] people are losing weight very quickly – up to 3lbs a week, they’re losing it very easily so they don’t feel hungry, but more importantly they’re all sustaining that weight loss.”

OHara adds that the science behind his firm’s technology has been around for a few years now but it’s taken time for the practice to catch up with the theory.

“We’ve had the science [for a little while], but sometimes science doesn’t work in practice. What we’re seeing now is that the actual products we’re creating and selling are working.”

The general public is starting to catch on as well, with OptiBiotix having to pump more money into its subsidiary The Health Weight Loss Company to keep up with demand."

[owenmo] 18/1/2017 08:56

I too, Judi, find it more than a little disconcerting - given Spring '17 expectation spanning a broad spectrum - that a former chairman would offload at this point. News on cholesterol front is less than a fortnight away, for God's sake.is there not, at the very least, a10% rise in the offing if news is even moderately encouraging and with prospects of an imminent product launch. Odd.

[bobdown2] 18/1/2017 08:45

She obviously thinks that opti is a good career move and that is a validation of the products.

[trotterstrading] 18/1/2017 08:36

Nice appointment and highly regarded in the sector. SoH is a frugal type, he won't have brought her in unless we are close to ramping up commercialisation IMHO

[john henry] 18/1/2017 08:34

JJ he probably wanted the funds for something, why do you sell ?? Ridiculous question.

[judijudi] 18/1/2017 08:26

As we are hopefully on the cusp of great things, I wonder why Evans has been off loading?

[someuwin] 18/1/2017 08:23

"...she was responsible for key consumer accounts including Sainsbury’s, Waitrose, M&S and Tesco."

[rafboy] 18/1/2017 08:20

Nice appointment and good to see we can attract such talent.

[nashwan123] 18/1/2017 07:57

Christina looks to be an A1 candidate having built her own business. Also agree that full sales roll out is not far off now and hopefully the explosion in revenues too.

[parob] 18/1/2017 07:56

I'm sure these new appointments will be offered share options as part of their package too - everyone will be working towards the same goal.Just imagine the contacts Per and Christina must have between them!

[shrewdmole] 18/1/2017 07:52

Worth noting soh raves about the low cash burn so if he has decided now is the time to be appointing big hitting directors then we must be very close to commercial rollout of products.

[bernieboy] 18/1/2017 07:35

Excellent appointment. Another brick in the Great Wall of Opti.

[parob] 18/1/2017 07:31

Another fantastic appointment, which will no doubt free up some of SOH's precious time so he can continue to develop and expand the business. Great CV!

[fozdad] 18/1/2017 07:09

Her CV looks like it's been designed specifically for OPTI !

[f3rdinand] 18/1/2017 07:07

OPTI certainly appointing some big hitters! I wonder what is attracting all this talent?

[primal123] 18/1/2017 07:06

RNS:Appointment of Sales and Marketing DirectorOptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol, diabetes and skin care, announces the appointment of Christina Wood as Sales and Marketing Director. Christina will join the OptiBiotix Board subject to completion of the normal regulatory due diligence.Christina has over 20 years' sales experience within the food, nutrition, and nutraceuticals industry. As the owner and CEO of Confoco, a supplier of high quality food ingredients worldwide, Christina grew the business from GBP1m to GBP10m sales by obtaining strategic supplier status with multiple global corporates including Nestlé, Danone, and Heinz. During this time, she developed a network of agents and distributors across key international markets. Christina sold her company to Diana Naturals in 2013 which was subsequently acquired by Symrise AG for US$1.75 billion in 2014. She joined John Morley, a leading food industry supplier, in late 2014 where as Director of Sales and Marketing, she was responsible for key consumer accounts including Sainsbury's, Waitrose, M&S and Tesco.She has been a finalist for Director of the Year for 'SME and International Trade' on two occasions and has been awarded the Nutricia Partners in Growth Award. Christina is fluent in German and Spanish.Christina has extensive experience in building and managing supply chain agreements across international markets with leading industry players, and has both business to business, and business to retail sales experience. Her sales and marketing experience within the food, nutrition, and nutraceuticals industry and network of global contacts will help grow revenues of OptiBiotix's products across multiple application areas and international markets.Stephen O'Hara, CEO of OptiBiotix, commented: "Christina's experience of building sales in her own business by developing relationships with food ingredient manufacturers and major retailers brings new elements of operational, commercial and industry expertise to OptiBiotix. Her skills in building and managing international networks of agents and distributors will be invaluable in taking OptiBiotix's patented SlimBiome(R) technology for hunger free weight loss and its LP-LDL(R) probiotic strain for cholesterol and hypertension reduction into overseas markets. This will help create multiple revenue streams from OptiBiotix's growing pipeline of products."

[scotty1] 18/1/2017 06:54

Optibiotix - David Evans share sale, panic not
PUBLISHED: 18 Jan 2017 @ 05:49

After hours yesterday it was announced that former NED David Evans had reduced his holding in Optibiotix (LSE:OPTI) from 3,478,732 shares (4.5%) to 2,623,517 shares (3.4%). Are we panicked?

Evans is a bit of a guru in this sector but he is old and is believed to have one or two health issues. He is not a director so can sell these shares while he cannot sell shares he owns in, say, Collagen (LSE:COS) where he is still on board.

If I get to his age (TW writing) I shall not be hoarding shares for the benefit of my nearest and dearest but will also be selling enough to bring in an extra shift of blonde, short skirted, Swedish nurses to attend to my every need..

The market may not react with glee to this news but we do not regard it as material. we expect very big positive news shortly and the shares are a buy at up to 80p with a target to sell of 100

[john henry] 17/1/2017 21:33

Qs99 you don't normally declare until you have completed selling.

[qs99] 17/1/2017 21:11

Great that he has declared his hand IMO and maybe that spike the other day signalled the end of his selling, let's see.

[john henry] 17/1/2017 21:04

If the share price starts to move into positive territory I will be adding for defo.